Guardian Pharmacy Services, Inc.

Healthcare

NYSE:GRDN · New York Stock Exchange

Market Cap $2.69B Beta 0.08 P/E (TTM) 52.0

$42.41 +0.39%

+$0.17 today

52W Low $19.30High $44.00

Vol 0.48M · Avg 0.48M

EPS (TTM) $0.84Medical - Distribution

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+108.71%

Period High

$43.40

Period Low

$19.88

Latest

$42.41

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Twist Bioscience Corporation

NASDAQ:TWST

$5.36B

10x Genomics, Inc.

NASDAQ:TXG

$4.44B

Edgewise Therapeutics, Inc.

NASDAQ:EWTX

$3.83B

National HealthCare Corporation

AMEX:NHC

$3.00B

Nuvation Bio Inc.

NYSE:NUVB

$1.89B

Pediatrix Medical Group, Inc.

NYSE:MD

$1.89B

Mesoblast Limited

NASDAQ:MESO

$1.84B

PROCEPT BioRobotics Corporation

NASDAQ:PRCT

$1.22B

QuidelOrtho Corporation

NASDAQ:QDEL

$901.48M

Janux Therapeutics, Inc.

NASDAQ:JANX

$851.95M

What is the latest GRDN filing?

The latest filing shown is 8-K dated May 28, 2026.

How many recent filings does GRDN have?

Intrinsic Alpha currently shows 20 recent filings for GRDN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.